Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 13 hours agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
Paxlovid Doesn't Cure Long COVID
Time Magazine· 2 days agoTaking the COVID-19 antiviral Paxlovid does not appear to improve Long COVID symptoms in a meaningful way, a new study finds. Paxlovid has long been a...
Paxlovid Fails to Quell Long Covid Symptoms in Stanford Study
Bloomberg· 2 days agoA 15-day course of Pfizer Inc.’s antiviral Paxlovid didn’t provide significant relief for long Covid...
Extended Course of Paxlovid Adds No Benefit for Those With Long COVID | FOX 28 Spokane
FOX 28 Spokane· 2 days agoAn extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new...
Clinical trial shows 15-day Paxlovid regimen safe but adds no clear benefit for long COVID
Medical Xpress· 2 days agoIn a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day...
Paxlovid Fails First Test in Long COVID
MedPage Today· 2 days agoA 15-day course of the antiviral nirmatrelvir-ritonavir (Paxlovid) didn't improve symptoms of long COVID, according to a randomized controlled trial that...
Retiree calls out Sask. gov't for not communicating changes to accessing COVID-19 drug Paxlovid
CBC via Yahoo News· 4 days agoA 63-year-old Saskatoon man says he has lost faith in the Saskatchewan government's health-care...
Scientists Race To Perfect New Oral COVID-19 Treatment Poised To Replace Paxlovid
SciTechDaily· 6 days agoRutgers researchers are advancing a potential new COVID-19 treatment, Jun12682, which is effective in animal studies and compatible with other medications, unlike the current leading treatment ...
What should you do if you’re still testing positive for COVID-19 after day 10?
The Today Show via AOL· 4 days agoThis occurs when people "pop back up as being positive even after a negative test," she explains....
Opinion | Paxlovid Trial Flops for COVID Pneumonia
MedPage Today· 3 days agoIn 2021, nirmatrelvir/ritonavir clearly decreased hospitalization and death among COVID-19 patients who had high risks of severe disease and who had not...
